Use of serological surveys to generate key insights into the changing global landscape of infectious disease

C. Jessica E Metcalf; Jeremy Farrar; Felicity T. Cutts; Nicole E. Basta; Andrea L. Graham; Justin Lessler; Neil M. Ferguson; Donald S. Burke; Bryan T. Grenfell

doi:10.1016/S0140-6736(16)30164-7

Use of serological surveys to generate key insights into the changing global landscape of infectious disease

C. Jessica E Metcalf, Jeremy Farrar, Felicity T. Cutts, Nicole E. Basta, Andrea L. Graham, Justin Lessler, Neil M. Ferguson, Donald S. Burke, Bryan T. Grenfell

Epidemiology

Research output: Contribution to journal › Comment/debate › peer-review

166 Scopus citations

Original language	English (US)
Pages (from-to)	728-730
Number of pages	3
Journal	The Lancet
Volume	388
Issue number	10045
DOIs	https://doi.org/10.1016/S0140-6736(16)30164-7
State	Published - Aug 13 2016

Bibliographical note

Funding Information:
JF is the director at the Wellcome Trust. FTC reports personal fees from the Bill & Melinda Gates Foundation, during the completion of this Personal View. NEB reports grants from the US National Institutes of Health (NIH) Director's Early Independence Award (number DP5OD009162), during the completion of this Personal View. NMF reports grants from the UK Medical Research Council, NIH National Institute of General Medical Sciences, Bill & Melinda Gates Foundation, and the UK NIH Research, during the completion of this Personal View. DSB reports travel reimbursements from Sanofi Dengue Vaccine Company, outside the submitted Personal View. DSB has a Provisional Patent Application (USA) for: new serological tests for HIV based on binding to biologically inspired non-biological chemical entities. CJEM, JL, and BTG report grants from the Bill & Melinda Gates Foundation. ALG declares no competing interests.

Funding Information:
We thank the Bill & Melinda Gates Foundation, the RAPIDD programme of the Science and Technology Directorate Department of Homeland Security and the Fogarty International Centre, National Institutes of Health (NIH), UK Medical Research Council, NIH National Institute of General Medical Sciences, and UK NIH Research for their financial support.

Access

10.1016/S0140-6736(16)30164-7

http://europepmc.org/articles/pmc5678936

OpenUrl availability

Full text

Cite this

@article{cf33943cd75e4560a42e2a0060d8810e,

title = "Use of serological surveys to generate key insights into the changing global landscape of infectious disease",

author = "Metcalf, {C. Jessica E} and Jeremy Farrar and Cutts, {Felicity T.} and Basta, {Nicole E.} and Graham, {Andrea L.} and Justin Lessler and Ferguson, {Neil M.} and Burke, {Donald S.} and Grenfell, {Bryan T.}",

note = "Funding Information: JF is the director at the Wellcome Trust. FTC reports personal fees from the Bill & Melinda Gates Foundation, during the completion of this Personal View. NEB reports grants from the US National Institutes of Health (NIH) Director's Early Independence Award (number DP5OD009162), during the completion of this Personal View. NMF reports grants from the UK Medical Research Council, NIH National Institute of General Medical Sciences, Bill & Melinda Gates Foundation, and the UK NIH Research, during the completion of this Personal View. DSB reports travel reimbursements from Sanofi Dengue Vaccine Company, outside the submitted Personal View. DSB has a Provisional Patent Application (USA) for: new serological tests for HIV based on binding to biologically inspired non-biological chemical entities. CJEM, JL, and BTG report grants from the Bill & Melinda Gates Foundation. ALG declares no competing interests. Funding Information: We thank the Bill & Melinda Gates Foundation, the RAPIDD programme of the Science and Technology Directorate Department of Homeland Security and the Fogarty International Centre, National Institutes of Health (NIH), UK Medical Research Council, NIH National Institute of General Medical Sciences, and UK NIH Research for their financial support. ",

year = "2016",

month = aug,

day = "13",

doi = "10.1016/S0140-6736(16)30164-7",

language = "English (US)",

volume = "388",

pages = "728--730",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10045",

}

TY - JOUR

T1 - Use of serological surveys to generate key insights into the changing global landscape of infectious disease

AU - Metcalf, C. Jessica E

AU - Farrar, Jeremy

AU - Cutts, Felicity T.

AU - Basta, Nicole E.

AU - Graham, Andrea L.

AU - Lessler, Justin

AU - Ferguson, Neil M.

AU - Burke, Donald S.

AU - Grenfell, Bryan T.

N1 - Funding Information: JF is the director at the Wellcome Trust. FTC reports personal fees from the Bill & Melinda Gates Foundation, during the completion of this Personal View. NEB reports grants from the US National Institutes of Health (NIH) Director's Early Independence Award (number DP5OD009162), during the completion of this Personal View. NMF reports grants from the UK Medical Research Council, NIH National Institute of General Medical Sciences, Bill & Melinda Gates Foundation, and the UK NIH Research, during the completion of this Personal View. DSB reports travel reimbursements from Sanofi Dengue Vaccine Company, outside the submitted Personal View. DSB has a Provisional Patent Application (USA) for: new serological tests for HIV based on binding to biologically inspired non-biological chemical entities. CJEM, JL, and BTG report grants from the Bill & Melinda Gates Foundation. ALG declares no competing interests. Funding Information: We thank the Bill & Melinda Gates Foundation, the RAPIDD programme of the Science and Technology Directorate Department of Homeland Security and the Fogarty International Centre, National Institutes of Health (NIH), UK Medical Research Council, NIH National Institute of General Medical Sciences, and UK NIH Research for their financial support.

PY - 2016/8/13

Y1 - 2016/8/13

UR - http://www.scopus.com/inward/record.url?scp=84962359530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962359530&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(16)30164-7

DO - 10.1016/S0140-6736(16)30164-7

M3 - Comment/debate

C2 - 27059886

AN - SCOPUS:84962359530

SN - 0140-6736

VL - 388

SP - 728

EP - 730

JO - The Lancet

JF - The Lancet

IS - 10045

ER -

Use of serological surveys to generate key insights into the changing global landscape of infectious disease

Bibliographical note

Access

OpenUrl availability

Other files and links

Cite this